Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients.
Lee IY, Hanft S, Schulder M, Judy KD, Wong ET, Elder JB, Evans LT, Zuccarello M, Wu J, Aulakh S, Agarwal V, Ramakrishna R, Gill BJ, Quiñones-Hinojosa A, Brennan C, Zacharia BE, Silva Correia CE, Diwanji M, Pennock GK, Scott C, Perez-Olle R, Andrews DW, Boockvar JA. Lee IY, et al. Among authors: andrews dw. Future Oncol. 2024 Mar;20(10):579-591. doi: 10.2217/fon-2023-0702. Epub 2023 Dec 7. Future Oncol. 2024. PMID: 38060340
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
Ali AS, Lombardo J, Niazi MZ, Miller RC, Alnahhas I, Martinez NL, Andrews DW, Judy KD, Shi W. Ali AS, et al. Among authors: andrews dw. J Neurooncol. 2022 Nov;160(2):345-350. doi: 10.1007/s11060-022-04146-w. Epub 2022 Nov 10. J Neurooncol. 2022. PMID: 36355259 Clinical Trial.
Predictors of recurrence after surgical resection of parafalcine and parasagittal meningiomas.
Khanna O, Barsouk A, Momin AA, Mahtabfar A, Andrews CE, Hafazalla K, Lan M, Patel PD, Baldassari MP, Andrews DW, Evans JJ, Farrell CJ, Judy KD. Khanna O, et al. Among authors: andrews ce, andrews dw. Acta Neurochir (Wien). 2023 Dec;165(12):4175-4182. doi: 10.1007/s00701-023-05848-4. Epub 2023 Nov 21. Acta Neurochir (Wien). 2023. PMID: 37987849
Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM).
Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW, Simone NL, Alnahhas I, Shi W. Cappelli L, et al. Among authors: andrews dw. J Clin Neurosci. 2024 Sep;127:110754. doi: 10.1016/j.jocn.2024.07.015. Epub 2024 Jul 27. J Clin Neurosci. 2024. PMID: 39068727
Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes.
Khanna O, Fathi Kazerooni A, Arif S, Mahtabfar A, Momin AA, Andrews CE, Hafazalla K, Baldassari MP, Velagapudi L, Garcia JA, Sako C, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Flanders AE, Shi W, Davatzikos C. Khanna O, et al. Among authors: andrews ce, andrews dw. Neurosurg Focus. 2023 Jun;54(6):E17. doi: 10.3171/2023.3.FOCUS2337. Neurosurg Focus. 2023. PMID: 37552657
301 results